Literature DB >> 8877704

Comparison of cyclic delta-opioid peptides with non-peptide delta-agonist spiroindanyloxymorphone (SIOM) using the message-address concept: a molecular modeling study.

P Gao1.   

Abstract

Based upon the message-address concept, this molecular modeling study used the delta-selective agonist spiroindanyloxymorphone (SIOM) as a molecular template for a conformational search and analysis of delta-selective opioid peptides. It was assumed that the tyramine moiety plays the same role for delta-opioid receptor recognition in both peptide and non-peptide ligands. Using 20 reported low-energy conformations of Tyr-cyclo[D-Cys-D-Pen]-OH (JOM-13) for comparison, the geometrical relationship of the two aromatic rings present in SIOM was used for the identification of potential active conformations of JOM-13, from which two delta-receptor-binding models (I and II) were constructed. Models I and II differ from each other in the arrangement of the peptide backbones. To evaluate the two models, a conformational search of two other known delta-selective ligands, [D-Pen2,D-Pen5]enkephalin (DPDPE) and [D-Pen2,L-Pen5]enkephalin (DPLPE) was performed, using the geometrical relationship of the two aromatic rings defined in the two receptor-binding models as a molecular template. Among the conformations generated from the molecular simulation, low-energy conformers of DPDPE and DPLPE conforming to models I and II were identified. Unlike model I, conformers of DPDPE and DPLPE that fit model II contain a cis amide bond in the Gly3 residue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877704     DOI: 10.1007/bf00124502

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  43 in total

1.  Theoretical study of the flexibility and solution conformation of the cyclic opioid peptides [D-Pen2,D-Pen5]enkephalin and [D-Pen2,L-Pen5]enkephalin.

Authors:  C Chew; H O Villar; G H Loew
Journal:  Mol Pharmacol       Date:  1991-04       Impact factor: 4.436

2.  Biosynthetic origin and receptor conformation of methionine enkephalin.

Authors:  A F Bradbury; D G Smyth; C R Snell
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

3.  Comparative conformational analysis of [D-Pen2,D-Pen5]enkephalin (DPDPE): a molecular mechanics study.

Authors:  B C Wilkes; P W Schiller
Journal:  J Comput Aided Mol Des       Date:  1991-08       Impact factor: 3.686

4.  Occurrence and role of cis peptide bonds in protein structures.

Authors:  D E Stewart; A Sarkar; J E Wampler
Journal:  J Mol Biol       Date:  1990-07-05       Impact factor: 5.469

5.  Proposal for the biologically active conformation of opiates and enkephalin.

Authors:  F A Gorin; G R Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

6.  A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists.

Authors:  P S Portoghese; S T Moe; A E Takemori
Journal:  J Med Chem       Date:  1993-08-20       Impact factor: 7.446

Review 7.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1995-07       Impact factor: 14.819

8.  Cyclic, disulfide- and dithioether-containing opioid tetrapeptides: development of a ligand with high delta opioid receptor selectivity and affinity.

Authors:  H I Mosberg; J R Omnaas; F Medzihradsky; C B Smith
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

9.  An unusual peptide conformation may precipitate amyloid formation in Alzheimer's disease: application of solid-state NMR to the determination of protein secondary structure.

Authors:  R G Spencer; K J Halverson; M Auger; A E McDermott; R G Griffin; P T Lansbury
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

10.  Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models.

Authors:  S D Bryant; M Attila; S Salvadori; R Guerrini; L H Lazarus
Journal:  Pept Res       Date:  1994 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.